REVIEW ARTICLE: REPUBLICATION |
|
Year : 2017 | Volume
: 3
| Issue : 3 | Page : 44-46 |
|
Retroperitoneal sarcomas
Stanislaw P Stawicki
OPUS 12 Foundation, Bethlehem, PA, USA
Correspondence Address:
Stanislaw P Stawicki Department of Research and Innovation, St. Luke's University Health Network, 801 Ostrum Street, Bethlehem, Pennsylvania 18015 USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/IJAM.IJAM_93_16
|
|
Retroperitoneal sarcomas (RS) are malignant tumors arising from mesenchymal cells, which are usually located in adipose, muscle, or connective tissue. RSs represent approximately 15% of all sarcomas and approximately 33–55% of all retroperitoneal tumors. The most common variants of RS include liposarcoma (40%), leiomyosarcoma (30%), and malignant fibrous histiocytoma (<10%). This article reviews the most important clinical characteristics of RSs, focusing on high-yield facts frequently encountered on standardized exams.
The following core competencies are addressed in this article: Medical knowledge, Patient care.
Republished with permission from: Stawicki SP. Retroperitoneal sarcomas. OPUS 12 Scientist 2007;1(1):17.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|